Balloon Eustachian Tuboplasty in Treatment of Chronic Eustachian Tube Dysfunction

NCT ID: NCT03556215

Last Updated: 2022-12-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-05-01

Study Completion Date

2020-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The prevalence of Eustachian tube (ET) dysfunction in adults reaches 1%. It causes a feeling of fullness in the ear, otalgia and hearing loss and can lead to recurrent acute otitis media, development of chronic otitis media with effusion and cholesteatoma. Endoscopic transnasal balloon ET dilatation is a novel surgical technique for ET dysfunction. The main goal is to restore ET function by dilation its cartilaginous part leading to better ventilation and drainage of the middle ear. However, its real effect in the treatment of particular subgroups of patients with ET dysfunction remains unknown. Patients are mostly evaluated as one group.

Adults with chronic ET dysfunction will be strictly divided into particular subgroups and included in the study. Subgroups will be compared in order to identify treatment effect in particular subgroups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The prevalence of Eustachian tube (ET) dysfunction in adults reaches 1%. It causes a feeling of fullness in the ear, otalgia and hearing loss and can lead to recurrent acute otitis media, development of chronic otitis media with effusion and cholesteatoma. Endoscopic transnasal balloon ET dilatation is a novel surgical technique for ET dysfunction. The main goal is to restore ET function by dilation its cartilaginous part leading to better ventilation and drainage of the middle ear. However, its real effect in the treatment of particular subgroups of patients with ET dysfunction remains unknown. Patients are mostly evaluated as one group.

Adults with chronic ET dysfunction will be strictly divided into particular subgroups and included in the study. The otomicro(endo)scopy, symptoms severity according to VAS (Visual Analogue Pain Scale), ETDQ-7 (Eustachian Tube Dysfunction Questionnaire) questionnaire, tympanometry, audiometry and the possibility of Valsalva and Toynbee maneuver will be used to evaluate the effect of balloon ET dilatation. Only patients with standard treatment failure will be included in the study. Tuboplasty with and without myringotomy will be performed (and compared) in patients with chronic otitis media with effusion. Subgroups will be compared in order to find patients who could profit from the treatments the most.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Eustachian Tube Dysfunction Chronic Recurrent Otitis Media Effusion After Tympanostomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Interventional parallel randomized controlled prospective trial
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

No masking was used in the study

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Effusion, Eustachian tube dilatation device and myringotomy

Patients with chronic Eustachian tube dysfunction and recurrence of chronic otitis media with effusion after tympanostomy tube exclusion, intervention: balloon Eustachian tuboplasty, and myringotomy

Group Type EXPERIMENTAL

Eustachian tube dilatation device

Intervention Type DEVICE

Balloon Eustachian tuboplasty will be performed using a Eustachian tube dilatation device.

Myringotomy

Intervention Type PROCEDURE

Myringotomy will be performed using a standard procedure.

Effusion, Eustachian tube dilatation device

Patients with chronic Eustachian tube dysfunction and recurrence of chronic otitis media with effusion after tympanostomy tube exclusion, intervention: balloon Eustachian tuboplasty only (no myringotomy)

Group Type EXPERIMENTAL

Eustachian tube dilatation device

Intervention Type DEVICE

Balloon Eustachian tuboplasty will be performed using a Eustachian tube dilatation device.

No effusion, Eustachian tube dilatation device

Patients with chronic Eustachian tube dysfunction and airy middle ear (without otitis media with effusion), Eustachian tube dilatation device, no myringotomy

Group Type EXPERIMENTAL

Eustachian tube dilatation device

Intervention Type DEVICE

Balloon Eustachian tuboplasty will be performed using a Eustachian tube dilatation device.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Eustachian tube dilatation device

Balloon Eustachian tuboplasty will be performed using a Eustachian tube dilatation device.

Intervention Type DEVICE

Myringotomy

Myringotomy will be performed using a standard procedure.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients with chronic Eustachian tube dysfunction lasting more than 6 months, with or without recurrence of chronic otitis media with effusion after tympanostomy

Exclusion Criteria

* anatomic obstruction in nasopharynx
* nasopharyngeal cancer
* head and neck cancer
* other middle ear surgery except for myringotomy or tympanostomy
* chronic suppurative otitis media
* patients who could not undergo general anesthesia
* patients who did not give consent to be included in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Hradec Kralove

OTHER

Sponsor Role collaborator

University Hospital Ostrava

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pavel Komínek, prof.,MD,Ph.D.,MBA

Role: STUDY_CHAIR

University Hospital Ostrava

Martin Formánek, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital Ostrava

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Hradec Králové

Hradec Králové, Hradec Králové Region, Czechia

Site Status

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, Czechia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Czechia

References

Explore related publications, articles, or registry entries linked to this study.

Swords C, Smith ME, Patel A, Norman G, Llewellyn A, Tysome JR. Balloon dilatation of the Eustachian tube for obstructive Eustachian tube dysfunction in adults. Cochrane Database Syst Rev. 2025 Feb 26;2(2):CD013429. doi: 10.1002/14651858.CD013429.pub2.

Reference Type DERIVED
PMID: 40008607 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MH CZ - DRO - FNOs/2016

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

FNO-ENT-BET

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.